Muscarine Mushroom Toxicity Follow-up
- Author: Peter A Chyka, PharmD, FAACT, DABAT; Chief Editor: Timothy E Corden, MD more...
Further Inpatient Care
- Administer intravenous fluids if vomiting becomes prominent, although this is rare.
- Provide psychiatric care to patients with intentional ingestions and suicidal thinking.
Deterrence/Prevention
- Avoid eating mushrooms that are not commercially cultivated for human consumption.
- Cautious mushroom hunters eat only one type of mushroom and save a sample in a dry, paper bag for later identification, if needed.
- Identification of mushrooms is best left to experts.
- Prevention is best achieved by eating only commercially cultivated mushrooms.
- Regularly remove mushrooms from sites where children are routinely present.
Prognosis
- The prognosis is excellent because many patients who ingest these mushrooms exhibit minor or no symptoms. Symptoms are typically self-limited, and patients recover without drug therapy. If needed, atropine relives most significant muscarinic symptoms.
Benjamin DR. Muscarine poisoning. In: Mushrooms: Poisons and Panaceas. New York, NY: WH Freeman; 1995:340-50.
Poisindex managements, mushrooms - muscarine / histamine. In: Poisindex System, internet database online [database online]. Greenwood Village (CO): Thomson Reuters (Healthcare); May 15, 2011.
Berger KJ, Guss DA. Mycotoxins revisited: Part I. J Emerg Med. Jan 2005;28(1):53-62. [Medline].
Berger KJ, Guss DA. Mycotoxins revisited: Part II. J Emerg Med. Feb 2005;28(2):175-83. [Medline].
Goldfrank LR. Mushrooms. In: Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR, Flomenbaum NE. Goldfrank's Toxicologic Emergencies. 9th. New York: McGraw-Hill; 2011:1522-36.
Diaz JH. Evolving global epidemiology, syndromic classification, general management, and prevention of unknown mushroom poisonings. Crit Care Med. Feb 2005;33(2):419-26. [Medline].
Diaz JH. Syndromic diagnosis and management of confirmed mushroom poisonings. Crit Care Med. Feb 2005;33(2):427-36. [Medline].
Bronstein AC, Spyker DA, Cantilena Jr LR, Green JL, Rumack BH, Griffin SL. 2009 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th annual report. Clin Toxicol. 2010;48:979-1178. [Full Text].
Pauli JL, Foot CL. Fatal muscarinic syndrome after eating wild mushrooms. Med J Aust. Mar 21 2005;182(6):294-5. [Medline].
NAMA (North American Mycological Association). Annual reports. North American Mycological Association, Toxicology Section. Available at http://www.namyco.org/toxicology. Accessed May 17, 2011.
West PL, Lindgren J, Horowitz BZ. Amanita smithiana mushroom ingestion: a case of delayed renal failure and literature review. J Med Toxicol. Mar 2009;5(1):32-8. [Medline].
Fischbein CB, Mueller GM, Leacock PR, Wahl MS, Aks SE. Digital imaging: a promising tool for mushroom identification. Acad Emerg Med. Jul 2003;10(7):808-11. [Medline].
Beuhler MC, Sasser HC, Watson WA. The outcome of North American pediatric unintentional mushroom ingestions with various decontamination treatments: an analysis of 14 years of TESS data. Toxicon. 2009;53:437-43.
[Best Evidence] [Guideline] Chyka PA, Seger D, Krenzelok EP, Vale JA. Position paper: Single-dose activated charcoal. Clin Toxicol (Phila). 2005;43(2):61-87. [Medline]. [Full Text].

